PUBLIC COMPANY
save$NGENNERVGEN PHARMA CORP.
$NGENVancouver, British Columbia, CAupdated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugsThe multi-drug partnership with Orbis Medicines—which Novo Holdings has backed since the biotech's seed rounds—is focused on cardiometabolic targets, but the technology at the center of the deal co…biospace · 15d ago
- Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotechNovo’s race to rejuvenate its cardiometabolic portfolio has seen the rebranded Danish pharma pen a $1.4 billion biobucks pact with oral macrocycle drug start-up Orbis Medicines.fiercebiotech · 16d ago
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that